Bellevue, Washington-based T-Mobile US, Inc. (TMUS) provides wireless communications services. Valued at a market cap of $220.7 billion, the company offers voice, messaging, and data services to postpaid, prepaid, wholesale and other services customers. It is ready to announce its fiscal Q4 earnings for 2025 after the market closes on Wednesday, Feb. 4. Before this event, analysts expect this telecom giant to report a profit of $2.14 per share, down 16.7% from $2.57 per share in the year-ago quarter. The ...

Core Viewpoint - T-Mobile US Inc. (NASDAQ:TMUS) is considered one of the best telecom stocks to invest in, with KeyBanc upgrading its rating from Underweight to Sector Weight, indicating a neutral risk/reward profile at current prices [1] Financial Performance and Projections - T-Mobile raised its FY25 outlook for postpaid net subscriber additions from 6.1-6.4 million to 7.2-7.4 million, reflecting an improvement of 1.05 million at the midpoint [3] - The company's core adjusted EBITDA forecast increased by $300 million at the midpoint to a range of $33.7-33.9 billion [3] - Net cash generated through operations guidance was enhanced by $600 million to a range of $27.8-28.0 billion [3] - T-Mobile also increased its capital expenditure plan from $9.5 billion to $10.0 billion to support its growing customer base and network expansion [3] Market Position and Services - T-Mobile US Inc. provides wireless communications services across the US, Puerto Rico, and the United States Virgin Islands, offering voice, messaging, and data services to various customer segments including postpaid, prepaid, and wholesale [4] Future Growth Expectations - KeyBanc anticipates that T-Mobile will experience an acceleration in organic growth rates following its planned investments in 2025, with the next major trigger for the stock being the fourth-quarter earnings release and the company's projections for 2026/2027 [2]

Meridian Funds, managed by ArrowMark Partners, released its “Meridian Hedged Equity Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. In the quarter, the market is more focused on the tailwind of policy easing than the headwind of weakening fundamentals, resulting in substantial gains despite stagflation emerging as a key concern. In this environment, the fund returned 1.67% (net) during the quarter, compared to 8.13% returns of the S&P 500 Index and 3.53% returns of th ...

Group 1 - A2Z Cust2Mate Solutions Corp. has secured a purchase order from Super Sapir for 3,000 smart shopping carts, marking it as one of the best-performing small-cap tech stocks in the past three years [1] - The total contract value is $30 million, structured as a long-term recurring-revenue model with Super Sapir paying a monthly fee per cart over a 60-month period [2] - A2Z Cust2Mate has exclusive rights to monetize digital services tied to the carts, including in-store advertising and data services, with a fixed fee for every thousand ads sold [3] Group 2 - The rollout of the smart carts is expected to begin in the first half of 2026, potentially marking a significant scaling milestone and adding a predictable recurring revenue stream for the company [4] - A2Z Cust2Mate's technology aims to transform brick-and-mortar retail by integrating hardware, software, and retail media into a unified in-store shopping platform [4]

Core Insights - Tempus AI is positioned to leverage its extensive healthcare data, with over 400 petabytes and access to more than 45 million patient records, to train advanced AI models that could significantly enhance the healthcare sector [2][3] Company Overview - Tempus AI has a market capitalization of less than $14 billion and is considered a potential major player in the AI healthcare space [2] - The company has established partnerships with nearly all (95%) of the top 20 oncology companies, enhancing its data utility [2] Product Lines - Tempus AI operates three main product lines: genomics, applications, and data services, which are integrated to enhance the overall value of its insights and data [3] Financial Performance - For the period ending September 30, Tempus reported revenue of $334.2 million, reflecting an 85% year-over-year increase, primarily driven by its genomics business, which more than doubled to $252.9 million [4] - The data and services segment experienced a more modest growth rate of 26% [4] Profitability Challenges - Despite strong revenue growth, Tempus is facing challenges with profitability, reporting an operating loss of just under $61 million, a 14% increase from the previous year [5] - The company's operating cash burn has increased from $149.8 million a year ago to over $181.3 million, raising concerns about potential dilution risks if additional capital is needed [5] Market Position and Investment Considerations - While Tempus AI has seen significant stock appreciation, caution is advised due to its high cash burn and lack of profitability improvement, suggesting a wait-and-see approach for potential investors [6][7]

Core Points - Verizon is providing free calling, texting, and data services for customers in Jamaica, Turks and Caicos, and the Bahamas from October 28 to November 12, 2025, in response to Hurricane Melissa [2][3][6] - The offer includes waiving charges for international calls from the US to these countries for consumer and small business wireless and landline customers [3][4] - Customers do not need to take any action to benefit from this offer, as calls will be rated at $0.00 per minute [4][6] Company Overview - Verizon Communications Inc. is a leading provider of technology and communications services, generating revenues of $136.8 billion in 2023 [5] - The company is headquartered in New York City and operates globally, offering data, video, and voice services on its networks [5]

Core Insights - Tempus AI, Inc. is recognized as a significant player in the AI sector on Wall Street, with a Buy rating and a price target of $110.00 set by Canaccord Genuity analyst Kyle Mikson, driven by the potential for AI deployment in clinical practice to enhance long-term revenue growth [1][3]. Group 1: Company Overview - Tempus AI, Inc. operates in the healthcare technology sector, providing AI-enabled precision medicine solutions, including oncology testing for genomic profiling and data services [3]. - The company has a strong acquisition strategy, exemplified by the Ambry deal, which is expected to enhance testing capabilities and AI functionalities, thereby accelerating growth [2][3]. Group 2: Financial Projections - The firm's DCF model for Tempus AI includes key assumptions such as a 10-year revenue compound annual growth rate (CAGR) of 22.8% and a peak operating margin of 45.6%, with a discount rate of 15.0% [3].

Core Viewpoint - Forge Global Holdings, Inc. is addressing media speculation regarding its potential sale and acknowledges unusual stock activity [1] Company Summary - Forge is a leading provider of marketplace infrastructure, data services, technology, and investment solutions for the private market [1] - The company typically does not respond to rumors or media speculation but felt the need to clarify its position due to current market activity [1]

Core Insights - Macquarie Asset Management's "Macquarie Large Cap Growth Fund" reported positive returns in Q3 2025 but underperformed the Russell 1000 Growth Index due to an unfavorable market environment and missteps [1] - AI-themed stocks were significant contributors to market gains, accounting for approximately 75% of market returns in the quarter [1] Fund Performance - The fund's performance lagged behind the benchmark, primarily due to not owning high-performing stocks like Tesla and the underperformance of its positions in Intercontinental Exchange, Inc. and Intuit Inc. [3] - The fund's top five holdings for 2025 were highlighted, indicating a focus on long-term structural trends despite short-term challenges [1] Intercontinental Exchange, Inc. (NYSE:ICE) - Intercontinental Exchange, Inc. experienced a one-month return of -8.12% and a 52-week loss of 4.15%, with a closing stock price of $158.27 and a market capitalization of $90.597 billion as of October 14, 2025 [2] - The company operates commodity exchanges and a mortgage technology business, but faced challenges due to slowed trading volumes, particularly in energy [3] - Despite recent underperformance, the fund believes ICE maintains a strong market position with potential for long-term growth driven by structural aspects of the energy market [3] Hedge Fund Interest - Intercontinental Exchange, Inc. was held by 84 hedge fund portfolios at the end of Q2 2025, a decrease from 94 in the previous quarter [5] - The company is not among the 30 most popular stocks among hedge funds, with a suggestion that certain AI stocks may offer better upside potential and lower downside risk [5]

Core Insights - The space industry is experiencing accelerated growth due to rising geopolitical tensions, rapid digitization, and increasing government-private partnerships, with Intuitive Machines (LUNR) and Rocket Lab (RKLB) emerging as key players [1][2] Financials and Growth Outlook - Rocket Lab ended 2024 with cash and cash equivalents of $419 million, current debt of $12 million, and long-term debt of $404 million, indicating a moderate solvency position [3] - The company secured over $450 million in new launch and space systems contracts in the previous year, including a significant $1.45 billion contract for a hypersonic test flight for the Department of Defense [4] - Additionally, Rocket Lab won a $5.6 billion award from the U.S. Space Force for national security missions, enhancing its revenue growth prospects [5] - Intuitive Machines concluded 2024 with cash and cash equivalents of $210 million and no debt, reflecting a solid solvency position [6] - The company is developing its largest lander, the Nova-M, expected to generate substantial revenues, and has a backlog of $328.3 million, a 22% year-over-year increase [7] Key Risks - Intuitive Machines faces risks related to its dependence on NASA-funded programs and the success of its lunar missions, which could impact future contract awards [8] - Rocket Lab's high operating expenses from investments in innovations may offset revenue gains, leading to losses [9] - Legal challenges, including a securities class action lawsuit, could affect Rocket Lab's investor confidence and future government contracts [10] Sales Estimates - The Zacks Consensus Estimate for Intuitive Machines' 2025 sales indicates a 19.2% year-over-year increase, while Rocket Lab's estimate suggests a 32.1% increase [11][12] Stock Performance - Over the past three months, Intuitive Machines' stock has decreased by 60.3%, while Rocket Lab's has decreased by 22.9%. However, over the past year, Intuitive Machines' shares surged by 66.7%, compared to Rocket Lab's 481.9% increase [14] Valuation - Intuitive Machines is trading at a forward sales multiple of 4.93X, which is more attractive compared to Rocket Lab's forward earnings sales of 15.18X [15] Return on Invested Capital - Both companies exhibit a negative Return on Invested Capital (ROIC), indicating insufficient profit generation from investments to cover capital costs [19] Conclusion - Both Intuitive Machines and Rocket Lab present opportunities in the evolving space economy, with LUNR's strong backlog and debt-free balance sheet positioning it for long-term growth, while RKLB's diversified business model offers near-term revenue visibility [20] - However, both companies face execution risks and earnings uncertainty, with LUNR's reliance on lunar missions and RKLB's high operating costs and legal issues potentially impacting performance [21][22]